We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$49.1M
Cap. Flow
-$51.9M
Cap. Flow %
-12.95%
Top 10 Hldgs %
77.61%
Holding
82
New
5
Increased
1
Reduced
3
Closed
2

Top Buys

1
IMMX icon
Immix Biopharma
IMMX
+$3.29M
2
CUE icon
Cue Biopharma
CUE
+$2.35M
3
MODD icon
Modular Medical
MODD
+$1.25M
4
IPWR icon
Ideal Power
IPWR
+$1.2M
5
TALK icon
Talkspace
TALK
+$680K

Top Sells

1
BC icon
Brunswick
BC
+$48.4M
2
LIN icon
Linde
LIN
+$11M
3
BLUE
bluebird bio
BLUE
+$1.87M
4
SLGCW
SomaLogic, Inc. Warrant
SLGCW
+$1.68K
5
FAZEW
FaZe Holdings Inc. Warrant
FAZEW
+$323

Sector Composition

1 Healthcare 17.02%
2 Industrials 16.95%
3 Materials 10.55%
4 Consumer Discretionary 10.23%
5 Financials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLTH
51
DELISTED
Cue Health Inc. Common Stock
HLTH
$189K 0.05%
1,000,000
– –
ARKOW
52
DELISTED
ARKO Corp Warrant
ARKOW
$165K 0.04%
333,333
– –
AMD icon
53
Advanced Micro Devices
AMD
$814B
$165K 0.04%
913
– –
CDNS icon
54
Cadence Design Systems
CDNS
$90.9B
$163K 0.04%
525
– –
LGF.B
55
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$153K 0.04%
16,413
– –
XOM icon
56
ExxonMobil
XOM
$615B
$125K 0.03%
1,075
– –
LILAK icon
57
Liberty Latin America Class C
LILAK
$1.49B
$115K 0.03%
18,174
– –
BNY
58
Bank of New York Mellon
BNY
$108B
$115K 0.03%
2,000
– –
ABBV icon
59
AbbVie
ABBV
$454B
$93.8K 0.02%
515
– –
RGF
60
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$72.2K 0.02%
16,667
– –
CMPOW
61
DELISTED
CompoSecure Inc Warrant
CMPOW
$70K 0.02%
100,000
– –
TER icon
62
Teradyne
TER
$50.6B
$67.7K 0.02%
600
– –
MO icon
63
Altria Group
MO
$124B
$52.3K 0.01%
1,200
– –
RVMDW icon
64
Revolution Medicines Inc Warrant
RVMDW
$97.9M
$36.5K 0.01%
200,000
– –
ARKF icon
65
ARK Blockchain & Fintech Innovation ETF
ARKF
$749M
$36.4K 0.01%
1,200
– –
LITE icon
66
Lumentum
LITE
$56.6B
$31.3K 0.01%
660
– –
T icon
67
AT&T
T
$152B
$29K 0.01%
1,650
– –
LILA icon
68
Liberty Latin America Class A
LILA
$1.49B
$28K 0.01%
5,913
– –
ARKW icon
69
ARK Web x.0 ETF
ARKW
$1.65B
$25K 0.01%
300
– –
XFOR icon
70
X4 Pharmaceuticals
XFOR
$357M
$24.8K 0.01%
596
– –
ARKG icon
71
ARK Genomic Revolution ETF
ARKG
$1.61B
$23.7K 0.01%
825
– –
OPFI.WS icon
72
OppFi Inc Warrants
OPFI.WS
$20K 0.01%
250,000
– –
RVMD icon
73
Revolution Medicines
RVMD
$39B
$17.9K ﹤0.01%
556
– –
SVREW
74
SaverOne 2014 Ltd Warrant
SVREW
$10.2K ﹤0.01%
121,000
– –
AENTW icon
75
Alliance Entertainment Holding Corp Warrants
AENTW
$3.77M
$7K ﹤0.01%
200,000
– –
1 2
3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q1 2024 Portfolio in Review

As of Q1 2024, Bleichroeder LP held 82 positions worth $401M, down 11% from $450M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bleichroeder LP withdrew a net $51.9M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Warrant, an estimated $1.68K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Materials.

Against the trend, Bleichroeder LP opened a new position in Immix Biopharma worth $2.61M.

  • Bleichroeder LP's largest Q1 2024 buy was Immix Biopharma: 850,000 shares worth $2.61M.
  • Bleichroeder LP added most to Cue Biopharma in Q1 2024, an estimated $2.35M increase.
  • Bleichroeder LP's biggest Q1 2024 reduction was Brunswick, cutting an estimated $48.4M.
  • Bleichroeder LP fully exited SomaLogic, Inc. Warrant in Q1 2024, selling an estimated $1.68K.
  • Bleichroeder LP's ten largest holdings make up 78% of its $401M portfolio in Q1 2024.
  • Bleichroeder LP opened 5 new positions and closed 2 in Q1 2024.
  • Bleichroeder LP's portfolio value fell 11% quarter-over-quarter to $401M.

Based on Bleichroeder LP's 13F filing for Q1 2024, filed 14 May 2024.